awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38946563-2CC95DD6-7317-408A-B829-F547CCA4E339
Q38946563-2CC95DD6-7317-408A-B829-F547CCA4E339
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38946563-2CC95DD6-7317-408A-B829-F547CCA4E339
Evaluation of the immunogenicity of the dabigatran reversal agent idarucizumab during Phase I studies.
P2860
Q38946563-2CC95DD6-7317-408A-B829-F547CCA4E339
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38946563-2CC95DD6-7317-408A-B829-F547CCA4E339
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3dc1377da6ef5745b3194a8cb59bea1150c24ea4
P2860
Immunogenicity to biologics: mechanisms, prediction and reduction.